Aràbia Saudita - anglès - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis ireland limited, ireland - rosuvastatin,ezetimibe - film-coated tablet - 20,10 mg,

Aràbia Saudita - anglès - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis ireland limited, ireland - rosuvastatin,ezetimibe - film-coated tablet - 40,10 mg,

Jordània - anglès - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة ألفه للأدوية - ulfa pharma co. - rosuvastatin 40 mg/1 tab , ezetimibe 10 mg/1 tab - 40 mg/1 tab , 10 mg/1 tab

Singapur - anglès - HSA (Health Sciences Authority)

servier (s) pte ltd - ezetimibe; rosuvastatin zinc eqv rosuvastatin - capsule - ezetimibe 10.00mg; rosuvastatin zinc eqv rosuvastatin 10.00mg

Singapur - anglès - HSA (Health Sciences Authority)

servier (s) pte ltd - ezetimibe; rosuvastatin zinc eqv rosuvastatin - capsule - ezetimibe 10.00mg; rosuvastatin zinc eqv rosuvastatin 20.00mg

Israel - anglès - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ezetimibe; rosuvastatin as calcium - film coated tablets - ezetimibe 10 mg; rosuvastatin as calcium 10 mg - rosuvastatin and ezetimibe - primary hypercholesterolaemia/homozygous familial hypercholesterolaemia (hofh):rosetemib s.k is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia.

Israel - anglès - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ezetimibe; rosuvastatin as calcium - film coated tablets - ezetimibe 10 mg; rosuvastatin as calcium 20 mg - rosuvastatin and ezetimibe - primary hypercholesterolaemia/homozygous familial hypercholesterolaemia (hofh):rosetemib s.k is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia.

Israel - anglès - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ezetimibe; rosuvastatin as calcium - film coated tablets - ezetimibe 10 mg; rosuvastatin as calcium 40 mg - rosuvastatin and ezetimibe - primary hypercholesterolaemia/homozygous familial hypercholesterolaemia (hofh):rosetemib s.k is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia.

Israel - anglès - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ezetimibe; rosuvastatin as calcium - film coated tablets - ezetimibe 10 mg; rosuvastatin as calcium 5 mg - rosuvastatin and ezetimibe - primary hypercholesterolaemia/homozygous familial hypercholesterolaemia (hofh):rosetemib s.k is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia.

Armènia - anglès - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

krka d.d. - rosuvastatin (rosuvastatin calcium), ezetimibe - tablets film-coated - 10mg+ 10mg